Regulation of Skp2-p27 Axis by the Cdh1/anaphase-promoting Complex Pathway in Colorectal Tumorigenesis

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2008 Jun 7

PMID 18535175

Citations 41

Authors

Takeo Fujita

Weijun Liu

Hiroyoshi Doihara

Yong Wan

Affiliations

Soon will be listed here.

Abstract

Abrogated entry into S phase is a common hallmark of cancer cells. Skp2, a subunit of ubiquitin ligase, is critical for regulating the G(1)/S transition. Uncontrolled Skp2 activity is detected frequently in human tumors, often correlated with poor prognosis. Current studies have suggested that the regulation of Skp2 turnover is mediated by another critical ubiquitin ligase, the anaphase-promoting complex (APC), in association with its substrate-specific factor Cdh1. To dissect the potential role of Cdh1/APC in tumorigenesis through the degradation of Skp2, we analyzed the Cdh1/APC-Skp2-p27 axis in colorectal tumorigenesis using a human tumor array and biochemical analyses. Our results show that the percentage of Cdh1- and p27-positive samples in colon cancer tissues was significantly lower than that in adjacent nonmalignant tissue. Conversely, the percentage of Skp2-positive colon cancer samples was significantly higher than that in normal tissue. Furthermore, results from clinicopathological analysis revealed that elevated Cdh1 expression was associated with lower histological grade tumors. In addition, depletion of Cdh1 by RNA interference in nonmalignant colon cells resulted in increased cellular proliferation, whereas knockdown of Skp2 significantly suppressed cancer cell growth. Our result suggests a pathological correlation between Skp2 and Cdh1/APC in colorectal cancer. Thus, Cdh1 may function as a component in tumor suppression via proteolysis of Skp2 in colorectal tumorigenesis and may serve as a prognostic marker in colon cancer patients.

Citing Articles

Strategy of combining CDK4/6 inhibitors with other therapies and mechanisms of resistance.

Xue Y, Zhai J Int J Clin Exp Pathol. 2024; 17(7):189-207.

PMID: 39114502 PMC: 11301413. DOI: 10.62347/HGNI4903.

Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review.

Ye M, Xu H, Ding J, Jiang L Breast Cancer (Dove Med Press). 2024; 16:181-197.

PMID: 38617842 PMC: 11016260. DOI: 10.2147/BCTT.S438366.

Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data.

Villa F, Crippa A, Pelizzoni D, Ardizzoia A, Scartabellati G, Corbetta C Int J Mol Sci. 2023; 24(19).

PMID: 37833875 PMC: 10572355. DOI: 10.3390/ijms241914427.

Inhibitory Effect of PPARδ Agonist GW501516 on Proliferation of Hypoxia-induced Pulmonary Arterial Smooth Muscle Cells by Regulating the mTOR Pathway.

Chen C, Yi C, Chen C, Tian L, Li L, Yang L Curr Med Sci. 2023; 43(5):979-987.

PMID: 37606736 DOI: 10.1007/s11596-023-2757-y.

Pellino 3 promotes the colitis-associated colorectal cancer through suppression of IRF4-mediated negative regulation of TLR4 signalling.

Kim Y, Kim H, Ha Thi H, Kim J, Lee Y, Kim S Mol Oncol. 2023; 17(11):2380-2395.

PMID: 37341064 PMC: 10620127. DOI: 10.1002/1878-0261.13475.

References

Wang C, Fisk B, Wadehra M, Su H, Braun J . Overexpression of murine fizzy-related (fzr) increases natural killer cell-mediated cell death and suppresses tumor growth. Blood. 2000; 96(1):259-63. View

Wang X, Liefer K, Tsai S, OMalley B, Roop D . Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis. Proc Natl Acad Sci U S A. 1999; 96(15):8483-8. PMC: 17542. DOI: 10.1073/pnas.96.15.8483. View

Lim M, Adamson A, Lin Z, Perez-Ordonez B, Jordan R, Tripp S . Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index. Blood. 2002; 100(8):2950-6. DOI: 10.1182/blood.V100.8.2950. View

Guo P, Imanishi Y, Cackowski F, Jarzynka M, Tao H, Nishikawa R . Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. Am J Pathol. 2005; 166(3):877-90. PMC: 1602359. DOI: 10.1016/s0002-9440(10)62308-5. View

Carrano A, Eytan E, Hershko A, Pagano M . SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999; 1(4):193-9. DOI: 10.1038/12013. View

Liu W, Wu G, Li W, Lobur D, Wan Y . Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition. Mol Cell Biol. 2007; 27(8):2967-79. PMC: 1899917. DOI: 10.1128/MCB.01830-06. View

Hershko D, Shapira M . Prognostic role of p27Kip1 deregulation in colorectal cancer. Cancer. 2006; 107(4):668-75. DOI: 10.1002/cncr.22073. View

Fang G, Yu H, Kirschner M . Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1. Mol Cell. 1998; 2(2):163-71. DOI: 10.1016/s1097-2765(00)80126-4. View

Weissman A . Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol. 2001; 2(3):169-78. DOI: 10.1038/35056563. View

10.

Datto M, Wang X . Ubiquitin-mediated degradation a mechanism for fine-tuning TGF-beta signaling. Cell. 2005; 121(1):2-4. DOI: 10.1016/j.cell.2005.03.017. View

11.

Winston J, Strack P, Chu C, Elledge S, Harper J . The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev. 1999; 13(3):270-83. PMC: 316433. DOI: 10.1101/gad.13.3.270. View

12.

Osoegawa A, Yoshino I, Tanaka S, Sugio K, Kameyama T, Yamaguchi M . Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer. J Clin Oncol. 2004; 22(20):4165-73. DOI: 10.1200/JCO.2004.01.035. View

13.

Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J . Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A. 2001; 98(9):5043-8. PMC: 33160. DOI: 10.1073/pnas.081474898. View

14.

Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda T, Mori M . Significance of skp2 expression in primary breast cancer. Clin Cancer Res. 2006; 12(4):1215-20. DOI: 10.1158/1078-0432.CCR-05-1709. View

15.

Hoeller D, Hecker C, Dikic I . Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer. 2006; 6(10):776-88. DOI: 10.1038/nrc1994. View

16.

Singhal S, Amin K, Kruklitis R, DeLong P, Friscia M, Litzky L . Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling. Cancer Biol Ther. 2003; 2(3):291-8. DOI: 10.4161/cbt.2.3.399. View

17.

Wan Y, Liu X, Kirschner M . The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction. Mol Cell. 2001; 8(5):1027-39. DOI: 10.1016/s1097-2765(01)00382-3. View

18.

Nakayama K, Nakayama K . Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer. 2006; 6(5):369-81. DOI: 10.1038/nrc1881. View

19.

Pagano M . Cell cycle regulation by the ubiquitin pathway. FASEB J. 1997; 11(13):1067-75. DOI: 10.1096/fasebj.11.13.9367342. View

20.

Shapira M, Kakiashvili E, Rosenberg T, Hershko D . The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells. Breast Cancer Res. 2006; 8(4):R46. PMC: 1779462. DOI: 10.1186/bcr1533. View